Outcome of colorectal cancer in Diamond-Blackfan syndrome with a ribosomal protein S19 mutation.
Chemotherapy
Colorectal cancer
Diamond–blackfan anemia
Ribosomal protein S19
Journal
Clinical journal of gastroenterology
ISSN: 1865-7265
Titre abrégé: Clin J Gastroenterol
Pays: Japan
ID NLM: 101477246
Informations de publication
Date de publication:
Dec 2020
Dec 2020
Historique:
received:
07
05
2020
accepted:
22
06
2020
pubmed:
10
7
2020
medline:
29
6
2021
entrez:
10
7
2020
Statut:
ppublish
Résumé
Diamond-Blackfan anemia is an autosomal dominant syndrome, characterized by anemia and a predisposition for malignancies. Ribosomal proteins are responsible for this syndrome, and the incidence of colorectal cancer in patients with this syndrome is higher than the general population. This patient's Diamond-Blackfan anemia was caused by a novel ribosomal protein S19 gene mutation, and he received chemotherapy for colorectal cancer caused by it. In his cancer, ribosomal proteins S19 and TP53 were overexpressed. He received 5FU and cetuximab; however, his anemia made chemotherapy difficult, and he did not survive long. Patients with Diamond-Blackfan anemia should be screened earlier and more often for colorectal cancer than usual.
Identifiants
pubmed: 32643123
doi: 10.1007/s12328-020-01176-7
pii: 10.1007/s12328-020-01176-7
doi:
Substances chimiques
Ribosomal Proteins
0
ribosomal protein S19
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM